Type 2 diabetes worldwide according to the new classification and criteria

Diabetes Care

Volumn 23, Issue SUPPL. 2, 2000, Pages

  Shaw, Jonathan E ^a,b   Zimmet, Paul Z ^a   McCarty, Daniel ^a   De Courten, Maximilian ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

AUTOIMMUNITY; CONFERENCE PAPER; DEVELOPING COUNTRY; DISEASE CLASSIFICATION; GLUCOSE BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL; POPULATION RESEARCH; PREVALENCE; SOCIOECONOMICS;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; GLUCOSE TOLERANCE TEST; HUMANS;

EID: 0034126363     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. Amos AF, McCarty DJ, Zimmet P: The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 14 (Suppl. 5):S7-S85, 1997
2. Finch CF, Zimmet PZ: Mortality from diabetes. In The Diabetes Annual/4. Alberti KGMM, Krall LP, Eds. Amsterdam, Elsevier, 1988, p. 1-16
3. Songer TJ, Zimmet PZ: Epidemiology of type II diabetes: an international perspective. Pharmacoeconomics 8 (Suppl. 1):1-11, 1995
4. Knowler W, Bennett P, Hamman R, Miller M: Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497-504, 1978
5. Dowse G, Zimmet P, Finch C, Collins V: Decline in incidence of epidemic glucose intolerance in Nauruans: implications for the thrifty genotype. Am J Epidemiol 133: 1093-1104, 1991
6. Dowse G, Spark R, Mavo B, Hodge AM, Erasmus RT, Gwalimu M. Knight LT, Koki G, Zimmet PZ: Extraordinary prevalence of non-insulin-dependent diabetes mellitus and bimodal plasma glucose distribution in the Wanigela people of Papua New Guinea. Med J Aust 160:767-774, 1994
7. Zimmet P, Taylor R, Ram P, King H, Sloman G, Raper LR, Hunt D: The prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a rural-urban comparison. Am J Epidemiol 118:673-688, 1983
8. Dowse G, Gareeboo H, Zimmet P, Alberti KGMM, Tuomilehto J, Fareed D, Brissonnette LG, Finch CF: High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole and Chinese Mauritians. Diabetes 39:390-396, 1990
9. Zimmet P: Kelly West Lecture 1991: Challenges in diabetes epidemiology: from West to the Rest. Diabetes Care 15:232-252, 1992
10. Zimmet P, Dowse GK, Finch CF, Serjeantson S, King H: The epidemiology and natural history of NIDDM: lessons from the South Pacific. Diabetes Metab Rev 6:91-124, 1990
11. Bennett PH, Bogardus C, Zimmet P, Tuomilehto J: The epidemiology of non-insulin dependent diabetes: non-obese and obese. In International Textbook of Diabetes Mellitus. Alberti KGMM, DeFronzo R, Keen H, Zimmet P, Eds. London, Wiley, 1992, p. 147-176
12. King H, Rewers M, Zimmet P, Dowse G: WHO Adhoc Reporting Group: global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 16:157-177, 1993
13. Zimmet P, Lefebvre P: The global NIDDM epidemic: treating the disease and ignoring the symptom (Editorial). Diabetologia 39: 1247-1248, 1996
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
15. Alberti KGMM, Zimmet PZ, for the WHO Consultation Group: Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
16. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
17. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
18. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA: Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303, 1994
19. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R: UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes: UK Prospective Diabetes Study Group. Lancet 350:1288-1293, 1997
20. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
21. lc levels for diagnosing diabetes: diagnostic criteria and performance revisited. Diabetes Care 20: 785-791, 1997
22. McCance DR, Hanson RL, Charles MA, Jacobsson LTH. Pettitt DJ, Bennett PH, Knowler WC: Comparison of tests for glycated haemoglobin and fasting and 2-hour glucose concentrations as diagnostic methods for diabetes. BMJ 308:1323-1328, 1994
23. Finch CF, Zimmet PZ, Alberti KGMM: Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabet Med 7:603-610, 1990
24. Harris MI, Hadden WC, Knowler WC, Bennett PH: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the U.S. population aged 20-74 yr. Diabetes 36:523-534, 1987
25. Balkau B, Eschwege E, Tichet J, Marre M: Proposed criteria for the diagnosis of diabetes: evidence from a French epidemiological study. Diabetes Metab 23:428-434, 1997
26. Charles MA, Balkau B: Revision of diagnostic criteria for diabetes (Letter). Lancet 348:1657-1658, 1996
27. Cockram CS, Lau JTF, Chan AYW, Woo J, Swaminathan R: Assessment of glucose tolerance test criteria for diagnosis of diabetes in Chinese subjects. Diabetes Care 15:988-990, 1992
28. De Vegt F, Dekker JM, Stehouwer CDA, Nijpels G, Bouter LM, Heine RJ: The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance. Diabetes Care 21:1686-1690, 1998
29. DECODE Study Group: Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 317:371-375, 1998
30. Shaw, JE, de Courten M, Boyko EJ, Zimmet PZ: The impact on different populations of new diagnostic criteria for diabetes. Diabetes Care 22:762-766, 1999
31. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Companson of diabetes diagnostic categories in the US population according to 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 20:1859-1862, 1997
32. Unwin N, Alberti KGMM, Bhopal R, Harland J, Watson W, White M: Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK. Diabet Med 15: 554-557, 1998
33. Chang C-J, Wu J-S, Lu F-H, Lee H-L, Yang Y-C, Wen M-J: Fasting plasma glucose in screening for diabetes in the Taiwanese population. Diabetes Care 21:1856-1860, 1998
34. Gimeno SGA, Ferreira SRG, Franco LJ, Iunes M, the Japanese-Brazilian Diabetes Study Group: Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. Diabetes Care 21:1889-1892, 1998
35. lc or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care 21:1221-1225, 1998
36. lc and fasting plasma glucose as first-line diagnostic tests for diabetes mellitus in non-pregnant subjects. Diabet Med 15:558-563, 1998
37. Gomez-Perez FJ, Aguilar-Salinas CA, Lopez-Alvarenga JC, Perez Jauregui J, Guillen-Pineda LE, Rull JA: Lack of agreement between the World Health Organization category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care 21:1886-1888, 1998
38. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, Forhan A, Eschwege E: High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. Diabetes Care 21:360-367, 1998
39. Barrett-Connor E, Ferrarra A: Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. Diabetes Care 21:1236-1239, 1998
40. Bjornholt JV, Erikssen G, Aaser E, Sandvik L, Nitter-Hauge S, Jervell J, Erikssen J, Thaulow E: Fasting blood glucose: an underestimated risk factor for cardiovascular death. Diabetes Care 22:45-49, 1999
41. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer H-M, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in U.S. adults. Diabetes Care 21:518-524, 1998
42. CDC Diabetes Cost-Effectiveness Study Group: The cost-effectiveness of screening for type 2 diabetes. JAMA 280:1757-1763, 1998
43. U.K. Prospective Diabetes Study Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
44. U K. Prospective Diabetes Study Group: Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
45. Larsson H, Berglund G, Lindgarde F, Ahren B: Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance. Diabetologia 21:1124-1125, 1998
46. Alberti KGMM: The clinical implications of impaired glucose tolerance. Diabet Med 13:927-937, 1996
47. Dowse GK, Zimmet PZ, King H: Relationship between prevalence of impaired glucose tolerance and NIDDM in a population. Diabetes Care 14:968-974, 1991
48. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H, Hemraj F, Fareeed D, Tuomilehto J, Alberti KGMM: Impaired fasting glucose or impaired glucose tolerance: what best predicts future diabetes? Diabetes Care 22: 399-402, 1999